Ritobegron ethyl ester hydrochloride

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameRitobegron ethyl ester hydrochloride
Drug Alias Nameๅˆฉๆ‰˜ๅ‹ƒ้š†ไน™้…ฏ็›้…ธ็›ๅˆฉๆ‰˜่ด้š†ไน™้…ฏ็›้…ธ็›ๅˆฉๆ‰˜่ด้š†KUC-7483 BSKUC-7483 +[6]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsUrinary Bladder, OveractiveSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksKEGG